All News
Consistent data that antimalarials did NOT decrease hospitalization for viral infections in the pre #COVID19 era in US claims database in SLE &RA pts #0002 @RheumNow @CRASCRRheum #ACR20 #ACR2020 https://t.co/nZp5dOeHXB
Janet Pope Janetbirdope ( View Tweet)
#COVID19 outcomes in systematic autoimmune diseases N=716 Pop’n matched by age & sex other COVID pts. Glass is half empty. More hospitalization, ICU, ventilation but death 5% v 4.3%. Abstr#430 #ACR20 @RheumNow @CRASCRRheum https://t.co/cqko0Igd8L
Janet Pope Janetbirdope ( View Tweet)
With #ACR20 fully #virtual, what gadget will you be using to access the meeting? @RheumNow
sheila RHEUMarampa ( View Tweet)
Dr Rubin of @NEJM on #vaccine development: safety and efficacy very important. Great keynote lecture! @RheumNow #ACR20 https://t.co/hVR2rmOMNp
sheila RHEUMarampa ( View Tweet)
Year in review by @JYazdanyMD ENTRACTE trial: CV safety of TCZ vs. ETN >similar CV events >TCZ grp slightly more infections & GI perforations @RheumNow #ACR20 https://t.co/yBDeHBDB3Z
sheila RHEUMarampa ( View Tweet)
Kaiser Permanente AFF study takeaways:
- risk of atypical #fracture ⬇ vs. other clinical fractures
- ⬆ risk in Asians
- consider drug holidays for pts on bisphosphonates
@RheumNow #ACR20 https://t.co/mq9zIh2iD5
sheila RHEUMarampa ( View Tweet)
How do you conduct your rheumatology clinics at present? @RheumNow #ACR20
sheila RHEUMarampa ( View Tweet)
DECT in #gout: color-coded lesions at MTP1 jt & patellar tendon exclusively pure MSU depositions. CCDL in gout: both pure MSU & calcium-containing depositios. @RheumNow #ACR20 Abs#0445 https://t.co/7zudk2muBR
sheila RHEUMarampa ( View Tweet)
Congrats to Dr S Izuka a clinical Rheumatolgy fellow for making a press release. Looking forward to full presentation next week. We published SLE pts had more adverse drug reactions than RA so I try to avoid sulfa drugs in SLE JRheum 2003;30:480-4 #ACR2020 https://t.co/spr6FsS1xg
Janet Pope Janetbirdope ( View Tweet)
During virtual meetings👨💻 👩💻 do you switch on your camera 📷? #Virtual #virtualmeetings
Dr. Antoni Chan synovialjoints ( View Tweet)
Think of Psoriatic Arthritis in the context of Psoriasis https://t.co/XpTFdzEHEa
Dr. Antoni Chan synovialjoints ( View Tweet)
COVID-19 has taught us to embrace virtual education. Viewing over 1700 posters is difficult when we have a big meeting but having virtual platform gives us the opportunity to do this now and interact with the presenters #ACR20 @RheumNow https://t.co/vwiDa34VYY
Dr. Antoni Chan synovialjoints ( View Tweet)
Honored to have our article "Using questions to enhance #rheumatology education" featured in the Medical Education Year in Review by @LisaCriscione at #ACR20. Read the full article here --> https://t.co/iDVvaxrTl5 #MedEd #rheum https://t.co/y78BP2qkqM
Jonathan Hausmann MD hausmannMD ( View Tweet)
Check out this session at 4 pm EST today on “Psoriatic Arthritis: Treatment in Practice” detailing emerging therapies and co-management strategies by this amazing team! #ACR20 @RheumNow https://t.co/baNtDLe6Rc
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Check https://t.co/FXLHCUIa5v to explore this concept further!
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
It’s that time of day/night at #ACR20, the votes are in, and the people have spoken. Coffee it is
@RheumNow https://t.co/XGmnGrPq5F https://t.co/bEoj15HnGl
David Liew drdavidliew ( View Tweet)
Should we in rheumatology be the ones leading the trials using our drugs with checkpoint inhibitors?
Can we learn lessons about collaborative work from @rheum_covid?
Provoking questions for the new challenges in treatment of irAEs! https://t.co/chl8TeOoMy
David Liew drdavidliew ( View Tweet)
Inflammation is not a single entity, and the imperative to dissect it carefully is so great in irAEs - in both treatment and measurement.
"I'm attempting to stir the pot" - @LCalabreseDO
- and there really is plenty to think about. https://t.co/8C6RbMI2l9
David Liew drdavidliew ( View Tweet)
One of my #ACR20 highlights about to start - irAE Study Group, hosted by @CCalabreseDO & @NohaMDAnderson
Imminent paradigm definition by @LCalabreseDO: one of the biggest challenges in the field: how to target therapies in irAEs, to maintain cancer response
#ACR2020 @RheumNow https://t.co/WzFbCc8TuT
David Liew drdavidliew ( View Tweet)
Just the beginning... trained over 1397 x-rays, this will only get better.
It could either:
- stop humans from having to do tedious things
- make Sharp/SvdH scores readily available in clinical practice/developing world/consistent in studies.
Either way, good!
tag @DrCMcMaster
David Liew drdavidliew ( View Tweet)